Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.309
Filter
1.
Chinese Journal of Contemporary Pediatrics ; (12): 37-41, 2024.
Article in Chinese | WPRIM | ID: wpr-1009890

ABSTRACT

OBJECTIVES@#To optimize the oxygen therapy regimens for infants with pulmonary diseases during bronchoscopy.@*METHODS@#A prospective randomized, controlled, and single-center clinical trial was conducted on 42 infants who underwent electronic bronchoscopy from July 2019 to July 2021. These infants were divided into a nasal cannula (NC) group and a modified T-piece resuscitator (TPR) group using a random number table. The lowest intraoperative blood oxygen saturation was recorded as the primary outcome, and intraoperative heart rate and respiratory results were recorded as the secondary outcomes.@*RESULTS@#Compared with the NC group, the modified TPR group had a significantly higher level of minimum oxygen saturation during surgery and a significantly lower incidence rate of hypoxemia (P<0.05). In the modified TPR group, there were 6 infants with mild hypoxemia, 2 with moderate hypoxemia, and 1 with severe hypoxemia, while in the NC group, there were 3 infants with mild hypoxemia, 5 with moderate hypoxemia, and 9 with severe hypoxemia (P<0.05). The modified TPR group had a significantly lower incidence rate of intraoperative respiratory rhythm abnormalities than the NC group (P<0.05), but there was no significant difference in the incidence rate of arrhythmias between the two groups (P>0.05).@*CONCLUSIONS@#Modified TPR can significantly reduce the risk of hypoxemia in infants with pulmonary diseases during electronic bronchoscopy, and TPR significantly decreases the severity of hypoxemia and the incidence of respiratory rhythm abnormalities compared with traditional NC.


Subject(s)
Infant , Humans , Oxygen , Bronchoscopy/adverse effects , Cannula , Prospective Studies , Electronics , Hypoxia/prevention & control , Lung Diseases
3.
Univ. salud ; 25(2): E19-E25, mayo-ago. 2023. tab
Article in Spanish | LILACS, COLNAL | ID: biblio-1510653

ABSTRACT

Introducción: La evaluación de los pacientes con tuberculosis pulmonar permite establecer metas de intervención en salud; el test de caminata de los 6 minutos, es ideal para observar la respuesta de todos los sistemas incluidos durante el ejercicio. Objetivo: Describir la respuesta fisiológica de algunas variables ventilatorias y cardiovasculares durante el test de caminata de los 6minutos en pacientes con secuelas de tuberculosis pulmonar, y sus posibles correlaciones de las variables fisiológicas con la distancia recorrida. Materiales y métodos: Estudio descriptivo de corte transversal en 21 pacientes con diagnóstico de secuelas de tuberculosis pulmonar, quienes asistieron a un programa de rehabilitación pulmonar, y realizaron test de caminata de los 6 minutos. Resultados: La edad media fue 49,33±18,82 años, en su mayoría hombres, la media de la distancia fue 348,35±127,833m. Hubo diferencia significativa durante los cuatro momentos analizados con un valor p<0,0001 en frecuencia cardiaca, frecuencia respiratoria y saturación de oxígeno. Hubo correlación fuerte para la edad, consumo de Oxígeno (VO2), número de detenciones, disnea modified Medical Research Council (mMRC), capacidad funcional medida en equivalentes Metabólicos (METS) y Saturación de Oxígeno (SpO2).Conclusión: Pacientes con secuelas de tuberculosis pulmonar en su mayoría hombres, evidencian cambios estadísticamente significativos durante la prueba.


Introduction:The assessment of patients with pulmonary tuberculosis is useful to establish health intervention goals. The 6-minute walk test is key to observing the response of all of the body systems involved in the exercise. Objective:To describe the physiological response of some ventilatory and cardiovascular variables during the 6-minute walk test in patients with pulmonary tuberculosis sequelae and possible correlations between physiological variables and the covered distance. Materials and methods:Descriptive cross-sectional study on 21 patients diagnosed with sequelae caused by pulmonary tuberculosis, who attended a pulmonary rehabilitation program and performed a 6-minute walk test. Results: The mean age of patients was 49.33±18.82 years, mostly men, and the mean distance was 348.35±127833 m. There was a significant difference in heart rate, respiratory rate andoxygen saturation during the four analyzed moments, with a pvalue < 0.0001. There was a strong correlation for age, oxygen consumption (VO2), number of stops, dyspnea modified Medical Research Council (mMRC), functional capacity measured as metabolic equivalents (METS) and oxygen saturation (SpO2). Conclusion:Most male patients with pulmonary tuberculosis sequelae show statistically significant changes during the test.


Introdução:A avaliação de pacientes com tuberculose pulmonar permite estabelecer metas de intervenção em saúde; O teste de caminhada de 6 minutos é ideal para observar a resposta de todos os sistemas incluídos durante o exercício. Objetivo: Descrever a resposta fisiológica de algumas variáveis ventilatórias e cardiovasculares durante o teste de caminhada de 6 minutos em pacientes com sequela de tuberculose pulmonar e suas possíveis correlações das variáveis fisiológicas com a distância percorrida. Materiais e métodos:Estudo transversal descritivo em 21 pacientes diagnosticados com sequelas de tuberculose pulmonar, que frequentavam um programa de reabilitação pulmonar, e realizaram o teste de caminhada de 6 minutos. Resultados:A média de idade foi de 49,33±18,82 anos, a maioria homens, a distância média foi de 348,35±127,833m. Houve diferença significativa nos quatro momentos analisados com valor de p< 0,0001 na frequência cardíaca, frequência respiratória e saturação de oxigênio. Houve uma forte correlação paraidade, consumo de oxigênio (VO2), número de paradas, dispneia modificada do Medical Research Council (mMRC), capacidade funcional medida em equivalentes metabólicos (METS) e saturação de oxigênio (SpO2). Conclusão:Pacientes com sequelas de tuberculose pulmonar, em sua maioria homens, apresentam alterações estatisticamente significativas durante o exame.


Subject(s)
Humans , Adult , Middle Aged , Medical Examination , Lung Diseases , Physical Examination , Anthropometry
4.
Rev. colomb. cir ; 38(2): 243-251, 20230303. tab, fig
Article in Spanish | LILACS | ID: biblio-1417774

ABSTRACT

Introducción. La lobectomía pulmonar es uno de los procedimientos más frecuentes en la cirugía torácica en Colombia y a nivel mundial. El objetivo de este estudio fue proporcionar información sobre el comportamiento clínico de los individuos sometidos a este tipo de cirugías. Métodos. Estudio observacional retrospectivo en un Hospital Universitario de Cali, Colombia, que incluyó todos los pacientes sometidos a lobectomía pulmonar, por causas benignas o malignas, entre los años 2010 y 2020. La información se extrajo del registro institucional de cirugía de tórax, obteniendo datos demográficos, clínicos y patológicos. Resultados. Se evaluaron los registros clínicos de 207 individuos. El 55,5 % eran mujeres, la edad promedio fue 58 años y el 41 % tuvieron antecedente de tabaquismo. En el 51,6 % de los casos se diagnosticaron neoplasias, de las cuales el 47,8 % eran primarias de pulmón, siendo el adenocarcinoma el subtipo más común. Las enfermedades benignas no tumorales representaron el 48,3 % de los casos y la causa más frecuente fueron las infecciones, dentro de las que se incluyeron 17 casos de tuberculosis pulmonar. La técnica más frecuente fue la cirugía toracoscópica video asistida (82,6 %). Presentaron un porcentaje de reintervención del 5,8 %, 10,6 % de complicaciones severas y una mortalidad hospitalaria del 4,3 %. Conclusión. La población evaluada muestra una carga alta de comorbilidades y riesgo operatorio elevado; de forma consecuente, al compararla con otras series internacionales, se encontró un porcentaje mayor de complicaciones perioperatorias y mortalidad.


Introduction. The pulmonary lobectomies is one of the most common procedures in thoracic surgery in Colombia and worldwide. The objective of this study is to provide information on the clinical behavior of individuals who underwent this type of surgeries. Methods. Retrospective observational study at a University Hospital in Cali, Colombia, including all individuals who had pulmonary lobectomies, between the years 2010 to 2020 for benign and malignant causes. The information was extracted from the institutional registry of thoracic surgery, obtaining demographic, clinical and pathological data. Results. The clinical records of 207 individuals were evaluated, 55.5% were women, the average age was 58 years, and 41% had a history of smoking. Of these cases, 51.6% were diagnosed with neoplasms, of which 47.8% were primary lung neoplasms, with adenocarcinoma being the most common subtype. As for benign diseases, they represented 48.3% of the cases and the most frequent cause was infections, including 17 cases of pulmonary tuberculosis. The most frequent technique was video-assisted thoracoscopic surgery in 82.6%, with a reoperation rate of 5.8%, up to 10.6% of severe complications, a median hospital stay of 6 days, and a hospital mortality of 4.3%.Conclusion. The population evaluated shows a high burden of comorbidities and high operative risk; consequently, when compared with other international series, it shows a higher percentage of perioperative complications, hospital stay, and mortality.


Subject(s)
Humans , Thoracic Surgery , Lung Diseases , Postoperative Complications , Thoracoscopy , Mortality , Thoracic Surgery, Video-Assisted
5.
Int. j. morphol ; 41(1): 167-174, feb. 2023. ilus, tab, graf
Article in English | LILACS | ID: biblio-1430531

ABSTRACT

SUMMARY: The present study investigated the possible protective effects of melatonin on Bleomycin, Cisplatin and etoposide (BEP) chemotherapy regimens using immunohistochemistry. Forty male Wistar rats were divided into four groups of ten as; group 1 as untreated control; group 2 as BEP group which received the three cycles of 21 days' regimen each of 0.5¥ dose levels ofBEP (bleomycin 0.75 mg/kg, etoposide 7.5 mg/kg and cisplatin 1.5 mg/kg). Rats in the group 3 (MEL group) received 10 mg/kg/day melatonin once daily. Group 4 received the melatonin (30 min before the BEP injections) and BEP as in groups 2. Proliferating cell nuclear antigen (PCNA) staining was used to detect cell proliferation and caspase-3, caspase-9 and Caspase-8 were detected to investigate apoptosis. PCNA immunostaining in alveolar epithelium, alveolar macrophages and bronchus was weak to moderate in BEP group. However, diffuse and strong caspase immunoreactions for caspase-3, caspase 8- and caspase-9 were detected in the bronchioles epithelium, vascular endothelium, alveolar luminal macrophages in the BEP group. PCNA and caspase immunoreactivities in MEL and Mel + BEP groups were close to the control one. The surface are in the BEP group was significantly reduced as compared to the control one ((P0.05). It can be concluded that BEP regimen can affects negatively on lung tissue and melatonin inhibits lung tissue injuries during BEP chemotherapy.


El presente estudio investigó los posibles efectos protectores de la melatonina en los regímenes de quimioterapia con bleomicina, etopósido y cisplatino (BEP) mediante inmunohistoquímica. Cuarenta ratas Wistar macho se dividieron en cuatro grupos de diez: grupo 1, control sin tratar; grupo 2, quimioterapia con una dosis de 0,5x de BEP (0,75 mg/kg de bleomicina, 7,5 mg/ kg de etopósido y 1,5 mg/kg de cisplatino) con tres ciclos de 21 días cada uno. Las ratas del grupo 3 (grupo MEL) recibieron 10 mg/kg/día de melatonina una vez al día. El grupo 4 (Mel + BEP) recibió melatonina (30 minutos antes de las inyecciones de BEP) y BEP, como en los grupos 2. Se usó la tinción del antígeno nuclear de células en proliferación (PCNA) para detectar la proliferación celular y, caspasa- 3, caspasa-9 y caspasa-8 para investigar apoptosis. La inmunotinción de PCNA en el epitelio alveolar, los macrófagos alveolares y los bronquios varió de débil a moderada en el grupo BEP. Sin embargo, se detectaron inmunorreacciones difusas y fuertes para caspasa-3, caspasa 8- y caspasa-9 en el epitelio de los bronquiolos, endotelio vascular y macrófagos luminales alveolares. Las inmunorreactividades de PCNA y caspasa en los grupos MEL y Mel + BEP fueron similares a las del control. El área de superficie en el grupo BEP se redujo significativamente en comparación con el control (P0,05). Se puede concluir que la quimioterapia con BEP puede afectar negativamente al tejido pulmonar y la melatonina inhibe las lesiones durante la quimioterapia.


Subject(s)
Animals , Male , Rats , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Lung Diseases/prevention & control , Melatonin/administration & dosage , Antioxidants/administration & dosage , Bleomycin/adverse effects , Immunohistochemistry , Cisplatin/adverse effects , Rats, Wistar , Apoptosis/drug effects , Proliferating Cell Nuclear Antigen , Protective Agents , Etoposide/adverse effects , Lung Diseases/chemically induced
6.
Neumol. pediátr. (En línea) ; 18(2): 45-47, 2023. ilus, tab
Article in Spanish | LILACS | ID: biblio-1444644

ABSTRACT

Se realiza comentario de estudio de Israel en el cual analizan 75 pacientes pediátricos que utilizaron cánula nasal de alto flujo (CNAF) en domicilio, evaluando la seguridad, las indicaciones, los parámetros de utilización, la duración del tratamiento, los resultados clínicos y la satisfacción de los padres. Se acompaña de una revisión de la literatura del tema.


A comment is made on a study conducted in Israel analyzing 75 pediatric patients who used high-flow nasal cannula at home, evaluating safety, indications, utilization parameters, treatment duration, clinical outcomes, and parental satisfaction. It is accompanied by a literature review on the topic.


Subject(s)
Humans , Child , Cannula , Home Nursing , Lung Diseases/therapy , Sleep Apnea, Obstructive/therapy , Noninvasive Ventilation , Neuromuscular Diseases/therapy
7.
Neumol. pediátr. (En línea) ; 18(3): 83-86, 2023. tab, ilus
Article in Spanish | LILACS | ID: biblio-1517026

ABSTRACT

La hemosiderosis pulmonar idiopática (HPI) es una patología poco frecuente; su distribución geográfica, su incidencia y prevalencia se desconocen de manera exacta a nivel mundial. Tiene una fuerte asociación con condiciones autoinmunes y una adecuada respuesta al tratamiento inmunosupresor. A pesar de ser una patología grave, presenta una tasa de morbilidad y mortalidad mediana, siempre que se realice un diagnóstico y tratamiento precoz. Se presenta el caso clínico de una paciente femenina con diagnóstico de HPI quien cursó con la triada clásica de esta enfermedad: hemoptisis, anemia ferropénica e infiltrados pulmonares difusos. Se descartaron otras causas de hemorragia pulmonar difusa y se realizó el diagnóstico por biopsia pulmonar. Se trató con esteroides sistémicos e inhalados y azatioprina. Tras casi 2 años después del diagnóstico, estando sin tratamiento por 3 meses, presentó una exacerbación con hemorragia pulmonar masiva ocasionando el fallecimiento de la paciente.


Idiopathic pulmonary hemosiderosis (IPH) is a rare pathology; its geographic distribution, incidence and prevalence are not accurately known worldwide. It has a strong association with autoimmune conditions and has an adequate response to immunosuppressive treatment. Despite being a serious pathology, it has a medium morbidity and mortality rate, provided that early diagnosis and treatment is performed. We present the clinical case of a female patient diagnosed with IPH who presented with the classic triad of this disease: hemoptysis, iron deficiency anemia and diffuse pulmonary infiltrates. Other causes of diffuse pulmonary hemorrhage were ruled out and the diagnosis was made by lung biopsy. She was managed with systemic and inhaled steroids and azathioprine. After almost 2 years before the diagnosis, being without treatment for 3 month she had a massive pulmonary hemorrhage, causing the death of the patient.


Subject(s)
Humans , Female , Young Adult , Hemosiderosis/diagnosis , Hemosiderosis/drug therapy , Lung Diseases/diagnosis , Lung Diseases/drug therapy , Radiography, Thoracic , Tomography, X-Ray Computed , Risk Factors , Hemoptysis/etiology , Hemosiderosis/diagnostic imaging , Immunosuppressive Agents/therapeutic use , Lung Diseases/diagnostic imaging
8.
Article in English | LILACS | ID: biblio-1515536

ABSTRACT

ABSTRACT OBJECTIVE To translate and cross-culturally adapt the COPD in Low- and middle-income countries (LMICs) Assessment (COLA) questionnaire into Brazilian Portuguese, a case-finding instrument for chronic obstructive pulmonary disease (COPD). METHODS Translation and cross-cultural adaptation were completed in six steps: the original version was translated into Brazilian Portuguese by two native speakers of the target language; the translated versions were synthesized; back-translation was performed by two native speakers of the original language; the back-translation and the Brazilian Portuguese version of the COLA were reviewed and harmonized by an expert committee of specialists; and, then, the pre-final version was tested by 30 health professionals who were asked if the items were clear to understand. The acceptability, clarity, and understandability of the translated version were evaluated. A final review of the questionnaire was produced by the authors and approved by the author of the original questionnaire. RESULTS Some idiomatic, semantic, and experiential inconsistencies were identified and properly adjusted. Item 3 was considered the most unclear item (23,3%). Items 7, 8, and 9 presented clarity above 80% (93%, 90%, and 90%, respectively). Suggestions were discussed and incorporated into the tool and COLA was found to be clear and easy to understand. CONCLUSIONS The Brazilian version of the COLA was easily understood by healthcare professionals and adapted to Brazilian culture. Translation and cultural adaptation of the COLA instrument into Brazilian Portuguese can be an important case-finding instrument for chronic obstructive pulmonary disease in Brazil.


Subject(s)
Mass Screening , Surveys and Questionnaires , Pulmonary Disease, Chronic Obstructive , Language , Lung Diseases
9.
Oncología (Guayaquil) ; 33(3): [266-272], 2023.
Article in English, Spanish | LILACS | ID: biblio-1531956

ABSTRACT

Introducción:La inmunoterapia con pembrolizumab ha mejorado el pronóstico del cáncer de pulmón metastásico. En el presente caso se presenta la supervivencia extendidad y evolución de un paciente específico.Caso clínico:Hombre de 66 años, fumador. Diagnosticado de masa pulmonar en lóbulo infe-rior izquierdo de dimensiones 9 x 8 cm, con metástasis supra e infratentoriales intraaxiliares. Taller diagnóstico: Establecida como neoplasia de pulmón en estadio IVc, se comprobó el estado de PDL1 que positivo en un 80 % de la muestra de masa pulmonar. Debuta con me-tástasis cerebrales.Evolución: Se inció inmunoterapia con Pembrolizumab, el cual se mantubo hasta la presencia de un efecto secundario atribuido al pembrolizumab, cumpliendo 30meses de supervivencia hasta el cierre de esta observación no se reportó la muerte del paciente.Conclusiones:En el presente reporte, la determinación del biomarcador histológico PDL1 po-sitivo en cáncer de pulmón ayudo a prescribir un tratamiento con inmunoterpia dirigida, lo que demostró aumentar la supervivencia más allá que el tratamiento convencional con quimiote-rapia


Introduction: Immunotherapy with pembrolizumab has improved the prognosis of metastatic lung cancer. A specific patient's extended survival and evolution is presented in the present case.Clinical case: 66-year-old man, smoker. Diagnosed with a lung mass in the left lower lobe measuring 9 x 8 cm, with supra and infratentorial intra-axial metastases.Diagnostic workshop: To establisha stage IVc lung neoplasm, 80% of the lung mass sample was confirmed to be positive for PDL1.Evolution: Immunotherapy was started with Pembrolizumab, which was maintained until the presence of a side effect attributed to pembrolizumab, completing 30 months of survival until the closure of this observation, the patient's death was not reported.Conclusions: In the present report, the determination of the positive histological biomarker PDL1 in lung cancer helped prescribe treatment with targeted immunotherapy, which was shown to increase survival beyond conventional treatment with chemotherapy


Subject(s)
Humans , Male , Aged , Immunotherapy , Lung Neoplasms , Lung Diseases
10.
Article in Portuguese | LILACS | ID: biblio-1511458

ABSTRACT

INTRODUÇÃO: pacientes que tiveram Covid-19, independente do espectro clínico da doença, podem apresentar sintomas persistentes após a alta hospitalar por até 14 meses. Estes pacientes apresentam comprometimentos funcionais e de qualidade de vida sendo, portanto, indicada a reabilitação pulmonar. Este estudo avaliou os aspectos funcionais e a qualidade de vida de pacientes pós-Covid-19 atendidos em um programa de reabilitação pulmonar. MÉTODOS: trata-se de um estudo prospectivo do tipo coorte clínica. Os pacientes pós-Covid-19 que integraram um programa de reabilitação pulmonar por seis semanas consecutivas foram avaliados em relação às variáveis funcionalidade pelo Índice de Barthel e pela escala PCFS, e a qualidade de vida pelo SF-36 na admissão (T0) e após seis semanas de reabilitação (T1). RESULTADOS: Onze pacientes que participaram do estudo apresentaram melhora da funcionalidade tanto pelo Índice de Barthel (p<0,01) como pela escala PCFS (p<0,01) e, também, melhora da qualidade de vida nos domínios capacidade funcional (p< 0,01), limitação por aspectos físicos (p<0,05) e aspectos sociais (p<0,01) no T1 em relação ao T0. CONCLUSÃO: pacientes pós-Covid-19 apresentaram melhora da funcionalidade e da qualidade de vida após um programa de reabilitação pulmonar (AU),


INTRODUCTION: patients who have Covid-19, regardless of the clinical spectrum of the disease, may present, after hospital discharge, persistent symptoms for up to 14 months. These patients have functional and quality of life impairments and, therefore, pulmonary rehabilitation for six consecutive weeks is indicated. This article evaluated the functional aspects and quality of life of post-Covid-19 patients treated in a pulmonary rehabilitation program. METHODS: this is a prospective clinical cohort study. Post-Covid-19 patients who joined a pulmonary rehabilitation program were evaluated concerning the variables functionality by the Barthel Index and the PCFS scale, and quality of life by the SF-36 at admission (T0) and after six weeks of rehabilitation treatment (T1). RESULTS: Eleven patients who participated in the study showed improved functionality both by the Barthel Index (p<0.01) and the PCFS scale (p<0.01) and also improved quality of life in the functional capacity domains (p < 0.01), limitation due to physical aspects (p<0.05) and social aspects (p<0.01) at T1 compared to T0. CONCLUSION: post-Covid-19 patients showed improved functionality and quality of life after a pulmonary rehabilitation program (AU).


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Lung Diseases/rehabilitation
11.
Chinese Journal of Industrial Hygiene and Occupational Diseases ; (12): 552-554, 2023.
Article in Chinese | WPRIM | ID: wpr-986069

ABSTRACT

Objective: To investigate the clinical characteristics of patients with acute phosphine poisoning, and to follow up and evaluate the prognosis of patients. Methods: In May 2022, 12 patients with phosphine poisoning by respiratory inhalation in Beijing Chao-Yang Hospital of Capital Medical University were analyzed. The patients were treated with symptomatic support therapy. Three months later, patients were re-evaluated the symptoms of poisoning, pulmonary function and magnetic resonance imaging (MRI) of the brain to understand the prognosis of the phosphine poisoning. Results: The main symptoms of 12 patients were respiratory and central nervous system symptoms with hypoxia. The symptoms of poisoning improved after treatment. Follow-up found that the patients had different degrees of residual symptoms. Pulmonary function showed increased airway resistance. Airway challenge test was positive in some patients. MRI of the head of some patients showed small ischemic focus in bilateral frontal lobes. Conclusion: Acute phosphine poisoning may cause persistent damage to the respiratory system and central system, and residual symptoms after 3 months.


Subject(s)
Humans , Follow-Up Studies , Phosphines , Lung , Lung Diseases , Aluminum Compounds , Poisoning/diagnosis
12.
Rev. chil. enferm. respir ; 39(1): 108-113, 2023. ilus
Article in Spanish | LILACS | ID: biblio-1515102

ABSTRACT

Las calcificaciones pulmonares metastásicas, hacen referencia a una enfermedad metabólica, caracterizada por depósitos de calcio en tejido pulmonar sano. La etiología es amplia e incluye enfermedades malignas y benignas, siendo la falla renal la causa más frecuente. Es una condición, que, a pesar de ser frecuente, suele ser subdiagnosticada, por presentar pocos o ningún síntoma. Presentamos tres casos clínicos asociados a enfermedad renal crónica, pre y post trasplante.


Metastatic pulmonary calcifications refer to a metabolic disease, characterized by calcium deposits in healthy lung tissue. The etiology is broad and includes malignant and benign diseases, the kidney failure being the most frequent cause. It is a condition, which, despite being frequent, is usually underdiagnosed, because it presents few or no symptoms. We present three clinical cases associated with pre- and post-transplant kidney disease.


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Calcinosis/etiology , Renal Insufficiency, Chronic/complications , Lung Diseases/etiology , Respiratory Function Tests , Calcinosis/diagnostic imaging , Radiography, Thoracic , Tomography, X-Ray Computed , Lung Diseases/physiopathology , Lung Diseases/diagnostic imaging
13.
rev.cuid. (Bucaramanga.2010) ; 13(1): 1-13, 20221213.
Article in Spanish | LILACS, BDENF, COLNAL | ID: biblio-1369074

ABSTRACT

Introducción. El tratamiento farmacológico de la EPOC se realiza progresiva y escalonadamente de acuerdo a la gravedad y puede ser modificado en función de la respuesta al mismo, por lo cual se han desarrollado instrumentos con el fin de evaluar la satisfacción del paciente con los distintos sistemas de inhalación; sin embargo, estos instrumentos han sido diseñados en su mayoría para pacientes con Asma. Objetivo. Validar el instrumento FSI-10 y determinar el nivel de satisfacción de los dispositivos de inhaloterapia en pacientes con EPOC. Materiales y métodos. Estudio transversal prospectivo y de validación de contenido, muestreo probabilístico estratificado con afijación proporcional; población de 337 pacientes con diagnóstico EPOC de la provincia Centro del departamento de Boyacá, Colombia. Se evaluó el cuestionario FSI-10 mediante la prueba de esfericidad de Bartlett, Kaiser-Meyer-Olkin y alfa de Cronbach. Resultados. La prueba de esfericidad resultó estadísticamente significativa, sugiriendo la existencia de correlaciones dentro de la matriz de diez preguntas. La variación total explicable de las diez preguntas que corresponden a la versión del FSI 10 dio cuenta del 81 % de variabilidad. Los pacientes evaluados reportaron un nivel de satisfacción entre bastante a algo con los dispositivos de inhaloterapia. Conclusiones. Las propiedades psicométricas permiten su utilización en la satisfacción del paciente con dispositivos de medicación inhalada, sin presentar diferencias en la comprensión y teniendo resultado fiables. La satisfacción con los dispositivos de inhaloterapia no es muy alta en la mayoría de la población evaluada.


Introduction: COPD pharmacological treatment is progressively staggered according to severity, which can be modified based on its response. Therefore, instruments have been developed to assess patient satisfaction with different inhaler devices. However, these instruments have been designed mostly for patients with asthma. Objective: To validate the FSI-10 instrument and assess the degree of satisfaction with inhaler devices in COPD patients. Materials and Methods: A prospective cross-sectional study for content validation and stratified probability sampling with proportional allocation was conducted with 337 COPD patients in the Central province of the department of Boyacá, Colombia. The FSI-10 questionnaire was assessed using Bartlett's test of sphericity, Kaiser-Meyer-Olkin test and Cronbach's alpha. Results: The test of sphericity was statistically significant, suggesting the presence of a correlation within the ten-question test. Total explained variation of the FSI-10 questions accounted for 81% of the variation. Assessed patients reported a degree of satisfaction between fair to good with the use of inhaler devices. Conclusions: FSI-10 psychometric properties enable its use in assessing patient satisfaction with inhaler devices with no difference in understanding and reliability results. Satisfaction with inhaler devices is not very high among the majority of the population assessed.


Introdução. O tratamento farmacológico da DPOC é progressivo e escalonado de acordo com a gravidade e pode ser modificado de acordo com a resposta ao tratamento, por isso, foram desenvolvidos instrumentos para avaliar a satisfação do paciente com diferentes sistemas de inalação; no enta nto, esses instrumentos foram elaborados principalmente para pacientes com asma. Objetivo. Validar o instrumento FSI-10 e determinar o nível de satisfação com os dispositivos de inaloterapia em pacientes com DPOC. Materiais e métodos. Estudo transversal prospectivo e de validação de conteúdo, amostragem probabilística estratificada com alocação proporcional; população de 337 pacientes diagnosticados com DPOC na província central do departamento de Boyacá, Colômbia. O questionário FSI-10 foi avaliado usando o teste de esfericidade de Bartlett, Kaiser-Meyer-Olkin e o alfa de Cronbach. Resultados. O teste de esfericidade foi estatisticamente significativo, sugerindo a existência de correlações dentro da matriz de dez perguntas. A variação total explicável das dez perguntas correspondentes à versão FSI 10 foi responsável por 81 % da variabilidade. Os pacientes avaliados relataram um nível de satisfação entre bastante e moderada com os dispositivos de inaloterapia. Conclusões. As propriedades psicométricas permitem seu uso na satisfação do paciente com dispositivos de medicamentos inalados, sem diferenças na compreensão e resultados confiáveis. A satisfação com os dispositivos de inaloterapia não é muito alta na maioria da população avaliada.


Subject(s)
Humans , Male , Female , Reproducibility of Results , Lung Diseases
14.
Rev. colomb. reumatol ; 29(4)oct.-dic. 2022.
Article in English | LILACS | ID: biblio-1536196

ABSTRACT

Systemic sclerosis is an autoimmune disease whose etiology remains unknown. Some patients prove refractory and require other therapies. Recently, the use of mesenchymal stem cells (MSC) for the treatment of disease refractory to conventional treatments has been considered. We present a case of refractory systemic sclerosis; Wharton's jelly mesenchymal stem cell was given in response. Decrease in perioral wrinkles, reduced telangiectasia and decrease in modified Rodnan skin score were observed two years later. A decrease in brain natriuretic peptide and improved pulmonary function were also found. And improvement of pulmonary fibrosis on high resolution tomography and capillaroscopy changes. In conclusion, MSC infusion seems to be effective and safe treatment of refractory scleroderma


La esclerosis sistémica es una enfermedad autoinmune de etiología desconocida y difícil manejo. Algunos casos que se tornan refractarios requieren terapias alternativas, como las células madre mesenquimales (MSC). Presentamos un caso de esclerosis sistémica refractaria que se llevó a terapia con MSC de gelatina de Wharton. Tras dos años, se observó ∗ Corresponding disminución en arrugas peribucales, aumento en apertura bucal, reducción de telangiectasias y en Rodnan modificado. También hubo disminución del péptido natriurético cerebral y mejora de pruebas de función pulmonar desde los seis meses de seguimiento, con mejoría en fibrosis pulmonar en tomografía de alta resolución y cambios en la capilaroscopia. En conclusión, el tratamiento con infusión de MSC parece efectivo y seguro en esclerosis sistémica refractaria.


Subject(s)
Humans , Female , Middle Aged , Respiratory Tract Diseases , Scleroderma, Localized , Therapeutics , Biological Therapy , Skin and Connective Tissue Diseases , Cell Transplantation , Connective Tissue Diseases , Mesenchymal Stem Cell Transplantation , Hypertension, Pulmonary , Lung Diseases
15.
Arch. argent. pediatr ; 120(6): e272-e277, dic. 2022. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1399728

ABSTRACT

Existen numerosas entidades en la población pediátrica que pueden presentarse en forma de quistes o como lesiones de similares características. De estas patologías, las infecciosas son las más frecuentes. Se presenta el caso de una paciente oriunda de Bolivia con migración reciente a la Argentina que presentó una coinfección con tuberculosis e hidatidosis pulmonar. Ambas infecciones se pueden presentar con signos y síntomas similares y, aunque la asociación citada es poco frecuente en la bibliografía, ciertos mecanismos inmunitarios podrían intervenir en la coinfección de parásitos helmintos y micobacterias. Ambas patologías son infecciones prevalentes en nuestra región y deben ser tenidas en cuenta entre los diagnósticos diferenciales ante pacientes con imágenes quísticas o cavitarias pulmonares.


Numerous entities in the pediatric population can present in the form of cysts or as lesions with similar characteristics. Of the pathologies that can cause these images in children, infectious diseases are the most frequent. We present the case of a native of Bolivia with recent immigration to Argentina who presented a pulmonary co-infection with tuberculosis and hydatidosis. Both infections can present with similar signs and symptoms and although this association is rarely reported in the literature, certain immunological mechanisms could intervene in the causal association of co-infection between helminth parasites and mycobacteria. Both pathologies are very prevalent infections in our region and should be taken into account among the differential diagnoses in patients with cystic or cavitary pulmonary diseases.


Subject(s)
Humans , Female , Adolescent , Tuberculosis/complications , Tuberculosis/diagnosis , Cysts , Echinococcosis/diagnosis , Coinfection/diagnosis , Lung Diseases
16.
Rev. colomb. neumol ; 34(2): 25-37, July-Dec. 2022.
Article in English | LILACS, COLNAL | ID: biblio-1412772

ABSTRACT

Introducción: las enfermedades pulmonares pueden generar hospitalizaciones, estancias prolongadas, complicaciones e inclusive la muerte. Estas enfermedades repercuten negativamente en la capacidad inspiratoria y en la calidad de vida. Por lo tanto, el presente artículo pretende analizar los efectos del Método JaPer sobre la capacidad inspiratoria de los pacientes hospitalizados. Material y métodos: ensayo clínico aleatorizado inicialmente con 653 pacientes hospitalizados que pasó a 587 distribuidos en 2 grupos (Grupo experimental-GE: Método JaPer vs Grupo control-GC: uso convencional de inspirómetro volumétrico). Se determinó la capacidad inspiratoria máxima, caminata de los 6 minutos, antropometría y un cuestionario creado por los autores. Se aplicó un programa de entrenamiento de 2 semanas de 3 sesiones por día. Al GE se le aplicó el Método Japer con protocolo estandarizado para hacer ejercicios entre el 50 y el 80 % de la capacidad inspiratoria máxima del paciente y a los pacientes del GC se les realizó incentivo inspiratorio a inspiración máxima. Resultados: 587 pacientes (F:300 vs M:287) con edad promedio de 53.61±14.24 años, entre los cuales el 9.88 % tenía bajo peso, 17.89 % peso normal y el 27.26 % y 44.97 % sobrepeso y obesidad, respectivamente. Todos los participantes realizaron una caminata de 6 minutos para determinar los metros recorridos (GE: 387.70±47.59 vs GC: 371.30±49.10), velocidad (GE: 64.62±7.93 vs GC: 61.88±8.18) y el Vo2 estimado (GE: 9.96±0.79 vs GC: 9.69±0.82). Todas las variables y la capacidad inspiratoria máxima (GE: 1708.54±707.84 vs GC: 1448.83±692.79) determinaron pre y post entrenamiento. Conclusiones: el Método JaPer obtuvó mejores resultados en todas las variables evaluadas con diferencia significativa (p= <0.05) frente al grupo control, resaltando que la capacidad inspiratoria máxima aumentó en ambos grupos (GE:44 % vs GC:28 %; p= <0.05).


Introduction: Pulmonary diseases can generate hospitalizations, prolonged stays, complications and even death. These diseases have a negative impact on inspiratory capacity and quality of life. Therefore, this paper tries to analyze the effects of the JaPer method on the inspiratory capacity of hospitalized patients. Materials and methods: Randomized clinical trial initially with 653 patients, which went on to 587 hospitalized patients distributed in 2 groups (Experimental group: JaPer Method vs. Control group: Conventional use of volumetric inspirometer). Maximum inspiratory capacity, 6-minute walk, anthropometry, and a questionnaire created by the authors were determined. A 2-week training program of 3 sessions per day was applied. The GE applied the Japer Method with a standardized protocol to exercise between 50 and 80% of the patient's maximum inspiratory capacity, and the CG underwent inspiratory incentive at maximum inspiration. Results: 587 patients (F:300 vs M:287) with a mean age of 53.61±14.24 years and 9.88% of the population were underweight, 17.89% normal weight and 27.26% and 44.97% overweight and obese, respectively. All participants performed a 6-minute walk to determine meters traveled (GE: 387.70±47.59 vs CG: 371.30±49.10), speed (GE: 64.62±7.93 vs CG: 61.88±8.18) and estimated VO2 (GE: 9.96 ±0.79 vs CG: 9.69±0.82). All variables and maximal inspiratory capacity (GE: 1708.54±707.84 vs CG: 1448.83±692.79) were determined before and after training. Conclusions: The JaPer method obtained better results in all the variables evaluated with a significant difference (p=<0.05) compared to the control group. Highlighting that the maximum inspiratory capacity increased in both groups (GE:44% vs CG:28%; p=<0.05).


Subject(s)
Humans , Exercise , Inspiratory Capacity , Lung Diseases , Anthropometry , Walking , Speed Meters
17.
Rev. colomb. neumol ; 34(2): 47-58, July-Dec. 2022.
Article in Spanish | LILACS, COLNAL | ID: biblio-1412777

ABSTRACT

Mediante la disminución de los niveles de contaminación del aire los países pueden reducir la carga en morbilidad derivada de accidentes cerebrovasculares, cáncer de pulmón y neumopatías crónicas y agudas. Por lo tanto, el objetivo de esta investigación fue determinar los efectos a corto y largo plazo que tiene la contaminación ambiental sobre la salud de la población por medio de una revisión narrativa de tipo cualitativo y descriptivo. El método de búsqueda e identificación de los estudios se realizó por medio de las siguientes bases de datos electrónicas: Medline, Pubmed, Science Direct, entre otras; con un estado del arte de máximo 5 años posteriores a su fecha de publicación. De acuerdo con la búsqueda realizada en las bases de datos, se seleccionaron un total de 10 artículos en los cuales se encontraron diferentes efectos de la contaminación ambiental en la salud humana a nivel respiratorio, cardiovascular, hepático, neurológico, gestacional, inmunológico, entre otros sistemas a causa del material particulado encontrado en el ambiente como los son del PM 2.5, PM10 Y otros gases relacionados con la contaminación y los efectos sobre la salud. Los resultados de esta revisión narrativa confirman los efectos asociados a la contaminación ambiental a corto plazo y largo plazo del aumento de las concentraciones de las partículas contaminantes encontradas en el ambiente. Palabras claves: contaminación ambiental, partículas contaminantes, efectos corto plazo, efectos largo plazo, material particulado.


By lowering air pollution levels, countries can reduce the burden of disease from strokes, lung cancer, and chronic and acute lung diseases. Therefore, the objective of this research was to determine the short and long-term effects of environmental pollution on the health of the population through a qualitative and descriptive narrative review. The search and identification method of the studies was carried out through the following electronic databases: Medline, Pubmed, Science Direct, among others; with a state of the art of a maximum of 5 years after its publication date. According to the search carried out in the databases, a total of 10 were selected in which different effects of environmental pollution on human health were found at the respiratory, cardiovascular, liver, neurological, gestational, and immune levels, among other systems. due to particulate matter found in the environment such as PM 2.5, PM10 and other gases related to pollution and health effects. The results of this narrative review confirm the short-term and long-term effects associated with environmental pollution of increased concentrations of polluting particles found in the environment.


Subject(s)
Humans , Environmental Pollutants , Environmental Pollution , Particulate Matter , Lung Diseases , Morbidity , Stroke , Lung Neoplasms
18.
Rev. am. med. respir ; 22(3): 225-229, set. 2022. graf, ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1407075

ABSTRACT

La silicosis es producida por la inhalación mantenida de dióxido de silicio (SiO2). Los trabajos en canteras e industrias de roca ornamental, granito y pizarra, y marmolerías son las exposiciones clásicamente descriptas, junto al pulido con chorro de arena. El arenado de jeans, producción de mesadas de cocinas y baños han surgido más recientemente. Las presentaciones clínicas pueden clasificarse en silicosis crónica (sim ple, complicada y fibrosis pulmonar), silicosis acelerada y silicosis aguda, según los años de exposición y factores individuales. Se presenta un caso clínico de un paciente masculino de 78 años con silicosis crónica complicada, asintomático, diagnosticado en contexto de un examen prequirúrgico.


Silicosis is caused by sustained inhalation of silicon dioxide (SiO2). Work in quarries and industries of ornamental rock, granite and slate, and marble work, are the typi cally described types of exposure, together with sandblasting. Denim sandblasting and the production of kitchen and bathroom countertops have emerged more recently. Clinical presentations can be classified into chronic silicosis (simple, complicated, and pulmonary fibrosis), accelerated silicosis, and acute silicosis, depending on years of exposure and individual factors. We present a clinical case of a 78-year-old male pa tient with complicated chronic silicosis, asymptomatic, diagnosed in the context of a pre-surgical examination.


Subject(s)
Male , Lung Diseases , Occupational Diseases
19.
Rev. colomb. reumatol ; 29(3)jul.-sep. 2022.
Article in English | LILACS | ID: biblio-1536186

ABSTRACT

Granulomatosis with polyangiitis is a systemic vasculitis that affects medium and small vessels, with high expression of anti-neutrophil cytoplasmic autoantibody. A case is pre sented on a patient with an initial compromise of the lower airway, who did not respond to management, required intensive care unit management, and died due to severe diffuse alveolar hemorrhage. His definitive diagnosis was established with a clinical autopsy. Gran-ulomatosis with polyangiitis is a disease with different ways of presentation, and can have fatal outcomes if it is not diagnosed early.


La granulomatosis con poliangeítis es un tipo de vasculitis que afecta a vasos de mediano y pequeño calibre de manera sistémica, con una alta expresión de anticuerpos contra el citoplasma del neutrófilo. Se presenta el caso de un paciente con un compromiso inicial de la vía área inferior, que no respondió al tratamiento y requirió manejo en unidad de cuidados intensivos. Finalmente, falleció por una hemorragia alveolar difusa severa. Su diagnóstico definitivo se estableció con una autopsia clínica. La granulomatosis con poliangeítis tiene diferentes formas de presentación y puede tener desenlaces fatales si no se diagnostica a tiempo.


Subject(s)
Humans , Male , Adolescent , Cardiovascular Diseases , Respiratory Tract Diseases , Vasculitis , Granulomatosis with Polyangiitis , Systemic Vasculitis , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Lung Diseases
20.
Rev. am. med. respir ; 22(2): 122-124, jun. 2022.
Article in Spanish | LILACS, BINACIS | ID: biblio-1441116

ABSTRACT

Desde las publicaciones iniciales de pacientes afectados por la COVID-19 en diciembre de 2019, ni la Organización Mundial de la Salud (OMS - WHO) ni los organismos sanitarios gubernamentales, hubiesen podido prever la magnitud de la morbimortalidad global provocada por este virus que se produjo y produce hasta la actualidad. La afección ha provocado formas clínicas leves, moderadas y graves; estas últimas son las que necesitaron internación y dieron lugar a secuelas que ameritaron su difusión para alertar a la comunidad médica


Subject(s)
Humans , Indicators of Morbidity and Mortality , Pandemics , Lung Diseases
SELECTION OF CITATIONS
SEARCH DETAIL